AI SOLUTIONS FOR LIFE SCIENCES
Put AI to work safely, practically and compliantly.
Life Science organizations know AI can transform the way work gets done. The challenge is moving from experimentation to solutions that deliver measurable value while protecting data, maintaining appropriate controls and operating within a regulated environment.
Assurea combines life sciences domain expertise, AI development and digital compliance to help organizations identify, build, implement and govern AI solutions designed around real business processes.
We identify high-value problems and build AI solutions that solve them.
What Challenges Do We Solve?
Making AI analysis fast, trustworthy and compliant for regulated teams.
Your experts are spending too much time reviewing documents
Quality and Regulatory teams can spend hundreds of hours manually reviewing audit reports, SOPs, deviations, CAPAs, validation records and other documentation. We use AI to structure and analyze information at scale, helping your experts identify what matters faster.
Important patterns are hidden across your data
A single deviation, CAPA or supplier audit may tell you very little. Hundreds of records can reveal recurring issues, systemic risks and trends that are difficult to identify through traditional review. Assurea helps organizations uncover the intelligence hidden across large document sets.
Generic AI tools aren’t designed for regulated work
Uploading hundreds of pages into a general-purpose AI tool isn’t the same as performing structured analysis. Assurea’s approach structures information into traceable factual units before analysis, allowing findings to be linked back to their source evidence.
You need to trust the output
In regulated environments, an AI-generated answer isn’t enough. Findings need context, evidence and appropriate human oversight. Our solutions combine structured analysis, domain-specific AI agents and expert human review to produce outputs that are traceable and verifiable.
You are concerned about using AI in a GxP environment
We help establish intended use, risk classification, human oversight, governance and validation strategies appropriate to the way the technology will actually be used.
Your AI pilots aren’t reaching production
We help bridge the gap between experimentation and operational deployment.
Why Assurea for AI?
AI technology meets life sciences expertise.
The real value of AI isn’t the model. It’s knowing how to apply it to the right problem. Assurea brings together AI technology, Quality, Regulatory, Validation and life sciences expertise to build solutions around the way regulated organizations actually operate.
Fast to deploy — many engagements require no software installation or integration.
Flexible — delivered as a service for a defined problem, or as a dedicated AI application for repeatable enterprise use.
Our Services
Identifying high-value problems and building solutions for them.
+AI Analytics & Intelligence Services
- Supplier Quality & Risk Intelligence
- Deviation, CAPA & Root Cause Analytics
- QMS & M&A Harmonization Analysis
- SOP & Procedure Gap Analysis
- Manufacturing & Tech Transfer Intelligence
- Periodic Review & System Intelligence
- Document & Regulatory Intelligence
- Cross-site Quality Trend & Risk Analysis
+AI Validation & Qualification
- AI/ML context of use-case & GxP impact assessments
- AI/ML risk classification & validation strategy
- AI supplier & vendor assessments
- Model credibility, performance, robustness & verification assessments
- AI/ML requirements, testing protocols & reports
- AI audit & inspection readiness
+Ongoing Monitoring & Lifecycle Management
- Model performance, drift & data quality monitoring
- Retraining, model improvement & release governance
+Custom AI Solutions & Agentic AI
- Custom AI Applications for Life Sciences
- AI Agents & Agentic Workflows
- Enterprise Knowledge Assistants
- Intelligent Document Review & Automation
- Retrieval-Augmented Generation (RAG) Solutions
- AI-Powered Dashboards & Decision Support
+AI Governance & Controls
- Enterprise AI governance policies & frameworks
- AI/ML data governance, provenance & dataset traceability
- Security, privacy & data protection assessments
- Human-in-the-loop oversight, traceability & explainability controls
- AI/ML change control & configuration management
- AI literacy & role-based training
Two Flexible Delivery Models
AI-Powered Services
Assurea operates the AI solution on your behalf. No software installation or system integration is required. Clients provide documents securely and receive expert-reviewed findings through reports and custom dashboards.
Custom AI Applications
Assurea designs a dedicated AI application around your processes, data and users, with tailored workflows, user interfaces, analytics and the ability to scale over time.
Related Insights
September 17, 2026
What Can AI Analyze in Biopharma Manufacturing? 5 Practical Manufacturing and MSAT Use Cases
How AI powered analysis can help manufacturing and MSAT teams understand batch performance, yield, quality, investigations and technology transfer using data they already have Biopharma manufacturing teams already collect a lot of data. Batch records. Process parameters. In-process testing. Yield and recovery data. QC results. Deviations. Development reports. Tech transfer documents. The challenge is often
September 10, 2026
Case Study: Using Manufacturing Intelligence to Improve AAV Batch Performance
How historical AAV manufacturing data can uncover process optimization opportunities and help Process Development and MSAT focus their investigations AAV manufacturing generates large amounts of data across manufacturing systems, process historians, batch records, in-process testing and QC laboratories. But the data is often reviewed one batch or one system at a time. That makes it
August 25, 2026
Assurea × Seeq Corporation: A New Partnership for GxP-Regulated Analytics
We’re excited to announce a new partnership between Assurea and Seeq to help pharma and biotech organizations adopt Seeq for Pharma within GxP-regulated environments. Assurea will serve as the implementation and validation partner for Seeq. As part of the partnership, Assurea has developed a validation package for Seeq that combines Assurea’s expertise in CSV and
August 23, 2026
Case Study: Using AI Analytics to Transform GxP Periodic Reviews
27 periodic reviews. 650+ documents analyzed. One clear view of system health. Periodic reviews are intended to answer a relatively simple question: is this GxP system or piece of computerized equipment still operating in a controlled and appropriately validated or qualified state? Getting to that answer is rarely simple. A reviewer may need to look
August 17, 2026
Contract & SLA Checklist for SaaS and AI Vendors in Pharma GxP Environments
Pharma companies cannot rely on standard commercial SaaS contracts alone when regulated systems, GxP data, or AI-enabled workflows are involved. In regulated environments, contracts and SLAs help define operational oversight expectations that support validation, data integrity, cybersecurity, supplier governance, and inspection readiness. Most commercial agreements are designed around uptime and commercial liability. Pharma and biotech
August 5, 2026
AI Manufacturing Intelligence for Technology Transfer: Reducing Manual Master Batch Record Reviews
How AI-powered document analytics helps manufacturing teams compare complex documentation, identify process differences, and accelerate technology transfer while keeping GMP decisions under human oversight. Technology Transfer Is Still a Documentation-Intensive Process Successful technology transfer is about far more than moving a manufacturing process from one facility to another. It requires ensuring that manufacturing knowledge is
July 21, 2026
Reducing Post-Acquisition QMS Integration Effort with AI
How Assurea helped a biotechnology company assess and align site vs global QMS following an acquisition using AI-assisted analytics and expert quality review. Project Overview Following the acquisition of a biotechnology company, our client needed to understand how the acquired site’s Quality Management System (QMS) aligned with its global quality framework before beginning integration activities.
May 28, 2026
How to Define Intended Use for AI and SaaS Tools in Pharma
Defining intended use is one of the most important steps in validating AI and SaaS tools in regulated pharma and biotech environments. The intended use statement establishes validation scope, testing strategy, risk classification, supplier oversight expectations, and procedural controls. For AI systems, this is often more difficult than traditional software because operational usage can evolve
April 9, 2026
AI Governance Frameworks That Work for Pharma
An AI governance framework for pharma works only when it goes beyond policy. It needs to connect each AI use case to a clear intended use, a defined risk tier, required controls, and ongoing monitoring. That is what makes the framework usable in practice and defensible in audit. If those links are missing, the framework
November 6, 2025
Case Study: AI-Driven Supplier Audit Data Summarization
Turning Supplier Audit Files into Actionable Insights for a Mid-Size Biotech Introduction A mid-size biotech organization with approximately 600 employees and a single GMP manufacturing site faced a common challenge: hundreds of supplier audit reports, self-assessment questionnaires, and CAPA summaries stored across multiple folders, but no easy way to extract trends or prioritize risks. The
August 27, 2025
Use Case: AI-Driven Trending and Adverse Events Data Analysis for Biotech Safety Surveillance
Scenario & Background A mid-sized biotech company developing a novel oncology cell therapy was running multiple Phase II trials across different sites. The company’s internal safety team was overwhelmed by the volume of adverse event (AE) reports and needed support in: However, the client did not want a new IT platform or continuous system integration.
August 11, 2025
Use Case: AI-Powered MBR vs. SOP Contradiction Check
In the biotech industry, the integrity of documentation is just as critical as the product itself. Master Batch Records (MBRs) guide the execution of production steps, while Standard Operating Procedures (SOPs) define how those steps should be performed and documented. These two document types are deeply interconnected, and any misalignment between them can lead to
July 30, 2025
Use Case: AI-powered Deviation Analysis
Scenario: A Biotech Company Analyzing 500+ Deviations to Uncover Trends and Gain Cross-Departmental Clarity A mid-sized biotech company had over 500 deviations logged at a single manufacturing site, spread across multiple departments including Quality, Manufacturing, Engineering, and Supply Chain. The data resided in their existing systems (QMS, Excel exports, reports), and they saw an opportunity
December 16, 2021
Blockchain in Pharma
Tanya Sharma, Co-Founder of Assurea LLC and Najib Rehman from ATMPS were excited when invited to join Jesse McLaughlin, host of Modern Biopharma Podcast ,to talk about how Blockchain – a new technology that is exploding in our industry – can be used to help us make a jump towards more available therapies for more
Ready to put AI to work in your organization?
Let’s talk about the problem you’re trying to solve.